Kreitman RJ, Moreau P, Ravandi F, Hutchings M, et al. Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia. Blood 2022 Sep 15. pii: 486621. doi: 10.1182/blood.2021013658.
PMID: 36108341